Circulating anti-double-stranded DNA antibody-secreting cells in patients with systemic lupus erythematosus: A novel biomarker for disease activity

Lupus

Volumn 21, Issue 12, 2012, Pages 1284-1293

  Hanaoka, H ^a   Okazaki, Y ^a   Satoh, T ^a   Kaneko, Y ^a   Yasuoka, H ^a   Seta, N ^a   Kuwana, M ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

anti DNA antibodies; B cells; biomarker; Systemic lupus erythematosus

Indexed keywords

DOUBLE STRANDED DNA ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE EXACERBATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEINURIA; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANIMALS; ANTIBODY-PRODUCING CELLS; AUTOANTIBODIES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COHORT STUDIES; DNA; ENZYME-LINKED IMMUNOSORBENT ASSAY; ENZYME-LINKED IMMUNOSPOT ASSAY; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED MRL LPR; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84867032428     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203312453191     Document Type: Article

References (30)

1. Tan EM. Pathophysiology of antinuclear antibodies in systemic lupus erythematosus and related diseases. Adv Dent Res. 1996 ; 10: 44-46
2. Munoz LE, Gaipl US, Herrmann M. Predictive value of anti-dsDNA autoantibodies: importance of the assay. Autoimmun Rev. 2008 ; 7: 594-597
3. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997 ; 40: 1725-1725
4. Ter Borg EJ, Horst G, Hummel EJ, Limburg PC, Kallenberg CG. Measurement of increases in anti-double strand DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. Arthritis Rheum. 1990 ; 33: 634-643
5. Ghirardello A, Villalta D, Morozzi G, et al. Evaluation of current methods for the measurement of serum anti double-stranded DNA antibodies. Ann N Y Acad Sci. 2007 ; 1109: 401-406
6. Isenberg DA, Manson JJ, Ehrenstein MR, Rahman A. Fifty years of anti-dsDNA antibodies: are we approaching journey's end?. Rheumatology. 2007 ; 46: 1052-1056
7. Tew JG, DiLosa RM, Burton GF, et al. Germinal centers and antibody production in bone marrow. Immunol Rev. 1992 ; 126: 99-112
8. Sze DM, Toellner KM, García de Vinuesa C, Taylor DR, MacLennan IC. Intrinsic constraint on plasmablast growth and extrinsic limits of plasma cell survival. J Exp Med. 2000 ; 192: 813-821
9. Hagiwara E, Ishigatsubo Y, Aoki A, Shirai A, Tani K, Okubo T. Preferential proliferation of anti-DNA producing cells of NZB mice in NZB.xid recipients. Autoimmunity. 1991 ; 9: 123-129
10. Wang X, Huang W, Schiffer LE, et al. Effects of anti-CD154 treatment on B cells in murine systemic lupus erythematosus. Arthritis Rheum. 2003 ; 48: 495-506
11. Odendahl M, Mei H, Hoyer BF, et al. Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response. Blood. 2005 ; 105: 1614-1621
12. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 ; 31: 315-324
13. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002 ; 61: 554-558
14. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 1980 ; 23: 581-590
15. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992 ; 35: 630-640
16. Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum. 1989 ; 32: 1107-1118
17. Cook RJ, Gladman DD, Pericak D, Urowitz MB. Prediction of short-term mortality in systemic lupus erythematosus with time dependent measures of disease activity. J Rheumatol. 2000 ; 27: 1892-1895
18. Kuwana M, Okazaki Y, Kaburaki J, Kawakami Y, Ikeda Y. Spleen is a primary site for activation of platelet-reactive T and B cells in patients with immune thrombocytopenic purpura. J Immunol. 2002 ; 168: 3675-3682
19. Kuwana M, Iki S, Urabe A. The role of autoantibody-producing plasma cells in immune thrombocytopenic purpura refractory to rituximab. Am J Hematol. 2007 ; 82: 846-848
20. Feltkamp TE, Kirkwood TB, Maini RN, Aarden LA. The first international standard for antibodies to double stranded DNA. Ann Rheum Dis. 1988 ; 47: 740-746
21. Ho A, Magder LS, Barr SG, Petri M. Decreases in anti-double stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus. Arthritis Rheum. 2001 ; 44: 2342-2349
22. Ehrenstein MR, Katz DR, Griffiths M, et al. Human IgG anti-dsDNA antibodies deposit in kidneys and induce proteinuria in SCID mice. Kid Int. 1995 ; 48: 707-711
23. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med. 2008 ; 149: 177-184
24. Jacob N, Stohl W. Autoantibody-dependent and autoantibody-independent roles for B cells in systemic lupus erythematosus: past, present, and future. Autoimmunity. 2101 ; 43: 84-97
25. Odendahl M, Jacobi A, Hansen A, et al. Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J Immunol. 2000 ; 165: 5970-5979
26. Arce E, Jackson DG, Gill MA, Bennett LB, Banchereau J, Pascual V. Increased frequency of pre-germinal center B cells and plasma cell precursors in the blood of children with systemic lupus erythematosus. J Immunol. 2001 ; 167: 2361-2369
27. Lee HT, Shiao YM, Wu TH, et al. Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis. J Rheumatol. 2010 ; 37: 45-52
28. Wang A, Guilpain P, Chong BF, et al. Dysregulated expression of CXCR4/CXCL12 in subsets of patients with systemic lupus erythematosus. Arthritis Rheum. 2010 ; 62: 3436-3446
29. Tan TC, Fang H, Magder LS, Petri MA. Differences between male and female systemic lupus erythematosus in a multi-ethnic population. J Rheumatol. 2012 ; 39: 759-769
30. De Carvalho JF, Do Nascimento AP, Testagrossa LA, Barros RT, Bonfa E. Male gender results in more severe lupus nephritis. Rheumatol Int. 2010 ; 30: 1311-1315